v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income $ 28,290 $ 247,953
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Investment (income) loss 4,918 (18,240)
Net realized and unrealized (gain) loss from consolidated funds’ investments 53,272 (65,698)
Accretion of original issue and market discount of consolidated funds’ investments, net (19,759) (18,589)
Income distributions from corporate investments in funds and companies 91,148 19,924
Other non-cash items 0 1,720
Cash flows due to changes in operating assets and liabilities:    
Net cash provided (used) in operating activities 277,733 (236,921)
Cash flows from investing activities:    
Purchases of U.S. Treasury and other securities 0 (250,000)
Corporate investments in funds and companies 0 (3,568)
Distributions and proceeds from corporate investments in funds and companies 2,500 120,711
Net cash provided (used) by investing activities 2,500 (132,857)
Cash flows from financing activities:    
Net cash (used) provided by financing activities (117,359) 480,021
Effect of exchange rate changes on cash    
Effect of exchange rate changes on cash 232 (4,187)
Net increase in cash and cash-equivalents 163,106 106,056
Supplemental Cash Flow Information    
Initial consolidation (deconsolidation) of funds 0 (770)
Cash and Cash Equivalents    
Cash and cash-equivalents, beginning balance 449,851 336,679
Cash and cash-equivalents, ending balance 612,957 441,965
Reconciliation of cash and cash-equivalents    
Total cash and cash-equivalents 612,957 441,965
Oaktree    
Cash flows due to changes in operating assets and liabilities:    
Increase in other assets (13,176) (217)
Decrease (increase) in net due from affiliates (776) 117,790
Decrease in accrued compensation expense (267) (50,901)
Increase (decrease) in accounts payable, accrued expenses and other liabilities (155) (165)
Cash flows from financing activities:    
Capital (distributions) contributions, net 39,811 (271)
Distributions to Class A unitholders (167,945) (14,758)
Distributions to OCGH unitholders 0 (7,658)
Distributions to preferred unitholders (6,829) (6,829)
Cash and Cash Equivalents    
Cash and cash-equivalents, ending balance 15,882 58,134
Reconciliation of cash and cash-equivalents    
Total cash and cash-equivalents 15,882 58,134
Consolidated Funds    
Cash flows due to changes in operating assets and liabilities:    
Increase (decrease) in accounts payable, accrued expenses and other liabilities 7,565 (80,463)
Decrease (increase) in dividends and interest receivable 6,533 (9,944)
Decrease (increase) in receivables for investments sold (68,333) 74,941
Decrease (increase) in other assets 4,497 (28,469)
Increase in payables for investments purchased 15,453 234,557
Purchases of investments (881,153) (1,226,773)
Proceeds from maturities and sales of investments 1,049,676 565,653
Cash flows from financing activities:    
Contributions from non-controlling interests 286,054 89,612
Distributions to non-controlling interests (367,821) (26,149)
Payment of debt issuance costs 0 (1,687)
Borrowings on credit facilities 470,730 871,492
Repayments on credit facilities (371,359) (423,731)
Cash and Cash Equivalents    
Cash and cash-equivalents, ending balance 597,075 383,831
Reconciliation of cash and cash-equivalents    
Total cash and cash-equivalents $ 597,075 $ 383,831